BOCH
MRKR icon

Blue Owl Capital Holdings’s Marker Therapeutics MRKR Stock Holding History

Blue Owl Capital Holdings’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$721K Hold
554,250
– – 0.19% 39
2025
Q4 		$826K Hold
554,250
– – 0.25% 40
2025
Q3 		$495K Hold
554,250
– – 0.15% 41
2025
Q2 		$848K Hold
554,250
– – 0.27% 38
2025
Q1 		$682K Hold
554,250
– – 0.22% 37
2024
Q4 		$1.72M Buy
+554,250
New +$1.96M 0.4% 31

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Blue Owl Capital Holdings's MRKR Position: Q1 2026 in Review

Blue Owl Capital Holdings held its Marker Therapeutics (MRKR) position steady in Q1 2026 at 554,250 shares worth $721K. The position accounts for 0.19% of the portfolio, ranked #39.

Blue Owl Capital Holdings first reported a position in MRKR in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.72M in Q4 2024. 35 funds tracked by Wall St. Rank hold MRKR as of Q1 2026.

  • Blue Owl Capital Holdings held 554,250 shares of Marker Therapeutics worth $721K as of Q1 2026.
  • Blue Owl Capital Holdings left its Marker Therapeutics share count unchanged in Q1 2026.
  • Marker Therapeutics made up 0.19% of Blue Owl Capital Holdings's portfolio in Q1 2026, its #39 holding.
  • Blue Owl Capital Holdings first reported a position in Marker Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Blue Owl Capital Holdings's Marker Therapeutics position peaked at $1.72M in Q4 2024.
  • 35 funds tracked by Wall St. Rank held Marker Therapeutics as of Q1 2026.

Based on Blue Owl Capital Holdings's 13F filing for Q1 2026, filed 14 May 2026.